459 related articles for article (PubMed ID: 17541044)
1. Neuroleptic malignant syndrome.
Strawn JR; Keck PE; Caroff SN
Am J Psychiatry; 2007 Jun; 164(6):870-6. PubMed ID: 17541044
[No Abstract] [Full Text] [Related]
2. [The neuroleptic malignant syndrome in an adolescent. Its treatment with dantrolene, bromocryptin and diazepam].
Real Rodríguez B; Ruibal JL; Grande Rodríguez S; Sueiro Pita B
An Esp Pediatr; 1996 Jan; 44(1):60-2. PubMed ID: 8849063
[No Abstract] [Full Text] [Related]
3. [Neuroleptic malignant syndrome].
Nishijima K
Ryoikibetsu Shokogun Shirizu; 2003; (38):176-8. PubMed ID: 12876959
[No Abstract] [Full Text] [Related]
4. Electroconvulsive therapy in drug resistant neuroleptic malignant syndrome.
Patel AL; Shaikh WA; Khobragade AK; Soni HG; Joshi AS; Sahastrabuddhe GS
J Assoc Physicians India; 2008 Jan; 56():49-50. PubMed ID: 18472502
[TBL] [Abstract][Full Text] [Related]
5. The neuroleptic malignant syndrome: agent and host interaction.
Shalev A; Munitz H
Acta Psychiatr Scand; 1986 Apr; 73(4):337-47. PubMed ID: 2873715
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic malignant syndrome.
Levenson JL
Am J Psychiatry; 1985 Oct; 142(10):1137-45. PubMed ID: 2863986
[TBL] [Abstract][Full Text] [Related]
7. Parkinsonism-hyperpyrexia syndrome not related to antiparkinsonian treatment withdrawal during the 2003 summer heat wave.
Gaig C; Martí MJ; Tolosa E; Gómez-Choco MJ; Amaro S
J Neurol; 2005 Sep; 252(9):1116-9. PubMed ID: 15778809
[No Abstract] [Full Text] [Related]
8. Management of suspected neuroleptic malignant syndrome.
Velamoor VR; Swamy GN; Parmar RS; Williamson P; Caroff SN
Can J Psychiatry; 1995 Nov; 40(9):545-50. PubMed ID: 8574990
[TBL] [Abstract][Full Text] [Related]
9. [Neuroleptic malignant syndrome and related conditions].
Amore M; Montanari M
Minerva Psichiatr; 1992; 33(4):259-83. PubMed ID: 1363674
[TBL] [Abstract][Full Text] [Related]
10. [Drug-induced neuroleptic malignant syndrome].
Jitsuiki H; Yamashita H; Kozuru T; Yamawaki S
Nihon Naika Gakkai Zasshi; 2007 Aug; 96(8):1627-33. PubMed ID: 17802712
[No Abstract] [Full Text] [Related]
11. [Intensive care treatment for neuroleptic malignant syndrome].
Hensel M; Böhler K; Marnitz R; Binder C; von Brevern M
Anasthesiol Intensivmed Notfallmed Schmerzther; 2010 Jul; 45(7-8):448-55. PubMed ID: 20665353
[TBL] [Abstract][Full Text] [Related]
12. Neuroleptic malignant syndrome.
Nicholson D; Chiu W
Geriatrics; 2004 Aug; 59(8):36, 38-40. PubMed ID: 15332415
[No Abstract] [Full Text] [Related]
13. [Neuroleptic malignant syndrome].
Retamal P
Rev Med Chil; 1990 Jun; 118(6):679-85. PubMed ID: 1685596
[TBL] [Abstract][Full Text] [Related]
14. Exacerbating factors in neuroleptic malignant syndrome: comparisons between cases with death, sequelae, and full recovery.
Nagamine M; Yoshino A; Sakurai Y; Sanga M; Takahashi R; Nomura S
J Clin Psychopharmacol; 2005 Oct; 25(5):499-501. PubMed ID: 16160631
[No Abstract] [Full Text] [Related]
15. [Neuroleptic malignant syndrome].
Murak E
Psychiatr Pol; 1995; 29(3):349-58. PubMed ID: 7652088
[TBL] [Abstract][Full Text] [Related]
16. [Neuroleptic malignant syndrome].
Reingardiene D
Medicina (Kaunas); 2002; 38(1):1-5. PubMed ID: 12474710
[TBL] [Abstract][Full Text] [Related]
17. [Malignant neuroleptic syndrome and Clostridium difficile: causal association or mere coincidence?].
Salas de Zayas R; Cerdeño Gómez C; Dolera Moreno C; Mármol E
Med Intensiva; 2012; 36(1):63. PubMed ID: 22154227
[No Abstract] [Full Text] [Related]
18. Therapy of neuroleptic malignant syndrome.
Lazarus A
Psychiatr Dev; 1986; 4(1):19-30. PubMed ID: 3703852
[TBL] [Abstract][Full Text] [Related]
19. [Clinical aspects, pathogenesis and treatment of neuroleptic malignant syndrome].
Sep-Kowalikowa B
Psychiatr Pol; 1989; 23(1):44-53. PubMed ID: 2573100
[No Abstract] [Full Text] [Related]
20. Diagnosing and treating neuroleptic malignant syndrome.
Am J Psychiatry; 1986 May; 143(5):673-5. PubMed ID: 2870651
[No Abstract] [Full Text] [Related]
[Next] [New Search]
